LLR APC Annual Report 2023 -2024(481 KB) - LMSG/LLR APC annual report
Date added: 04th April 2024
Date added: 5th Apr 2024
| Drug Name | Classification | Clinical Indication | Comments |
|---|---|---|---|
| BELUMOSUDIL (Rezurock®) (NEW) | Red | For treating chronic graft-versus host disease after 2 or more systemic treatments in people 12 years and over. | |
| BUDESONIDE/ FORMOTEROL FUMARATE DIHYDRATE INHALER (GoResp Digihaler®) (UPDATED) | Red | Asthma & COPD |
Restricted to severe asthma clinic only on a named patient basis |
| FLUOCINOLONE ACETONIDE (Iluvien®) intravitreal implant | Red | Diabetic macular oedema |
In line with NICE TA953 |
| HYBRID CLOSED LOOP (NEW) | Red | Diabetes Glucose Monitoring & Delivery System |
In line with NICE TA943 |
| INFLIXIMAB | Red | All indications |
As indicated on the LLR Medicines Formulary |
| MODAFINIL (UPDATED) | Yellow | Daytime sleepiness associated with Narcolepsy and existing patients being treated for Daytime Sleepiness associated with Obstructive Sleep Apnoea Syndrome & Idiopathic Hypersomnia. | |
| NEFOPAM (NEW) | Red | For post-operative analgesia for patients undergoing THR / THK |
ONLY for patients who are intolerant of NSAIDs, tramadol and/or opioids. 5 – 7 days treatment only. |
| PARECOXIB (NEW) | Red | Single intra-operative dose for the management of acute postoperative pain. |
Only to be given to patients for whom PR diclofenac is not appropriate. |
| SOLRIAMFETOL (Sunosi ®) (UPDATED) | Yellow | For treating excessive daytime sleepiness caused by narcolepsy |
In line with NICE TA758 |
| TARGETED-RELEASE BUDESONIDE (NEW) | Red | for treating primary IgA nephropathy |
In line with NICE TA937 |
Other Updates on this Website
Recent documents from LLR APC and TAS
LLRAPC Meeting minutes February 2024(685 KB) - LMSG/LLR APC minutes
Date added: 4th Apr 2024
LLRAPC Meeting minutes March 2024(618 KB) - LMSG/LLR APC minutes
Date added: 4th Apr 2024
TAS Minutes 27th February 2024(236 KB) - TAS
Date added: 28th Mar 2024
TAS Minutes 28th November 2023(323 KB) - TAS
Date added: 28th Mar 2024
LLRAPC Newsletter – February and March 2024(743 KB) - LMSG/LLR APC newsletters
Date added: 27th Mar 2024
Transferring Care Safety: Response Timescales and Indicative (Agile) Criteria(220 KB)
Version 1 Uploaded March 2024
Date added: 25th Mar 2024
Transferring Care Safely Interface Guidance(402 KB)
Version 1 Uploaded March 2024
Date added: 25th Mar 2024
Minimising the risk of Look-Alike Sound-Alike medication errors(2 MB)
Version 1 Uploaded March 2024
Date added: 20th Mar 2024
Look Alike Sound Alike A-Listers(951 KB)
Version 1 Uploaded March 2024
Date added: 20th Mar 2024
Look alike sound alike (LASA) Items(1 MB)
Version 1 Uploaded March 2024
Date added: 20th Mar 2024
SCA: Colistin for Historic Cystic Fibrosis Patients(632 KB) - Shared care agreement
Version 3.0 Uploaded March 2024
Date added: 12th Oct 2020
Valproate/Valproic Acid Advice Following MHRA Alert(776 KB) - Guidelines
Version 1.8 Uploaded April 2024
Date added: 21st May 2019
Antimicrobial Guide for Primary Care(1 MB) - Guidelines
Version 23 Uploaded April 2024
Date added: 2nd May 2019
Continence Prescribing Formulary for LLR(1,016 KB) - Guidelines
Version 1.7 Uploaded April 2024
Date added: 9th Aug 2018
Guidelines for the Management of Catheterised Patients in the Community(184 KB) - Guidelines
Updated April 2024
Date added: 19th Apr 2017
Nutritional Management Following Bariatric Surgery(434 KB) - Guidelines
Version 1 Updated April 2024
Date added: 11th Aug 2016
Lithium Induced Arginine Vasopressin Resistance(803 KB) - Guidelines
Version 2.0 Uploaded April 2024
Date added: 9th Dec 2015
Primary Care Multi-resistant Lower UTI Guidance(731 KB) - Guidelines
Version 4.0 Uploaded April 2024
Date added: 21st Sep 2015
About the Leicester, Leicestershire and Rutland Area Prescribing Committee
In common with other local health communities, the Leicester, Leicestershire and Rutland Area Prescribing Committee (LLR APC) acknowledges the benefits of having a Leicestershire Health Community-wide strategy for the prescribing of specialist medicines and the managed entry of new drugs and related technologies.
Leicestershire Health Community comprises the Leicester, Leicestershire and Rutland Integrated Care Board, University Hospitals of Leicester (UHL) NHS Trust and Leicestershire Partnership NHS Trust (LPT), amongst which there is a total consensus on the need for this strategy, and the LLR APC has been in place since 2005. Learn more